Close Menu

NEW YORK (GenomeWeb) – Early genetic changes can be used to identify individuals who are at an increased risk of developing acute myeloid leukemia, according to a new study.

More than 19,500 people will be diagnosed with AML this year in the US, according to the National Cancer Institute. Patients typically exhibit few symptoms before the disease's abrupt onset, but an international team of researchers sought to identify those at increased risk.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Jun
26
Sponsored by
Lexogen

This webinar will outline a study that combined genome-wide and classical molecular approaches to demonstrate that translation strongly affects mRNA stability in a codon-dependent manner, ultimately influencing mRNA and protein levels in higher organisms.

Jul
23
Sponsored by
Qiagen

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Jul
30
Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.